Dale Ludwig

Dale Ludwig

Company: Actinium Pharmaceuticals

Job title: Chief Scientific Officer

Seminars:

Leveraging the Power of Radioimmunotherapy in Cancer Treatment: Radio-Conjugate Therapeutic Combinations and Targeted Conditioning Regimens for Cell Therapy 10:00 am

Strategic combinations of radiopharmaceuticals and targeted therapies Exploiting the potency of alpha and beta emitter radionuclide warheads to effectively condition patients prior to bone marrow transplant and adoptive cell therapiesRead more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.